BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30606107)

  • 21. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
    Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D
    Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
    Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
    Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
    Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
    J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.
    Sato T; Maekawa T; Watanabe S; Tsuji K; Nakahata T
    J Clin Invest; 2000 Jul; 106(2):263-70. PubMed ID: 10903342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Location and the functionality of erythropoietin receptor(s) in A2780 cells.
    Solár P; Hrčková G; Varinská L; Solárová Z; Kriška J; Uhrínová I; Kello M; Mojžiš J; Fedoročko P; Sytkowski AJ
    Oncol Rep; 2012 Jul; 28(1):141-6. PubMed ID: 22552716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of erythropoietin and its receptor increases in colonic neoplastic progression: the role of hypoxia in tumorigenesis.
    Gombos Z; Danihel L; Repiska V; Acs G; Furth E
    Indian J Pathol Microbiol; 2011; 54(2):273-8. PubMed ID: 21623073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
    Arcasoy MO; Karayal AF
    Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
    Um M; Gross AW; Lodish HF
    Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells.
    Elliott S; Busse L; McCaffery I; Rossi J; Sinclair A; Spahr C; Swift S; Begley CG
    J Immunol Methods; 2010 Jan; 352(1-2):126-39. PubMed ID: 19887071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin.
    Dunlop EA; Percy MJ; Boland MP; Maxwell AP; Lappin TR
    Neurodegener Dis; 2006; 3(1-2):94-100. PubMed ID: 16909043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
    Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
    Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin-receptor gene regulation in neuronal cells.
    Wallach I; Zhang J; Hartmann A; van Landeghem FK; Ivanova A; Klar M; Dame C
    Pediatr Res; 2009 Jun; 65(6):619-24. PubMed ID: 19218878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of functional erythropoietin receptors of cancer cell lines.
    Laugsch M; Metzen E; Svensson T; Depping R; Jelkmann W
    Int J Cancer; 2008 Mar; 122(5):1005-11. PubMed ID: 17990315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-secretion neutralization of transgene-derived effect: soluble erythropoietin receptor/IgG1Fc expressed in liver neutralizes erythropoietin produced in muscle.
    Maruyama H; Higuchi M; Higuchi N; Kameda S; Saito M; Sugawa M; Matsuzaki J; Neichi T; Yokoyama S; Miyazaki Y; Miyazaki J; Gejyo F
    J Gene Med; 2004 Feb; 6(2):228-37. PubMed ID: 14978776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells.
    Sinclair AM; Rogers N; Busse L; Archibeque I; Brown W; Kassner PD; Watson JE; Arnold GE; Nguyen KC; Powers S; Elliott S
    Br J Cancer; 2008 Mar; 98(6):1059-67. PubMed ID: 18349818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin-responsive sites in normal and malignant human lung tissues.
    Yasuda Y; Hara S; Hirohata T; Koike E; Yamasaki H; Okumoto K; Hoshiai H
    Anat Sci Int; 2010 Dec; 85(4):204-13. PubMed ID: 20397063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoR.
    McArthur GA; Longmore GD; Klingler K; Johnson GR
    Exp Hematol; 1995 Jul; 23(7):645-54. PubMed ID: 7601257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional significance of erythropoietin receptor expression in breast cancer.
    Arcasoy MO; Amin K; Karayal AF; Chou SC; Raleigh JA; Varia MA; Haroon ZA
    Lab Invest; 2002 Jul; 82(7):911-8. PubMed ID: 12118093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.
    Torregrossa F; Aguennouz M; La Torre D; Sfacteria A; Grasso G
    World Neurosurg; 2019 Nov; 131():346-355. PubMed ID: 31658577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.